Fil LTD Lowered Its Amdocs LTD (DOX) Stake by $3.67 Million as Stock Value Declined

September 30, 2018 - By Jason Dias

Amdocs Limited (NASDAQ:DOX) Logo

Fil Ltd decreased its stake in Amdocs Ltd (DOX) by 1.21% based on its latest 2018Q2 regulatory filing with the SEC. Fil Ltd sold 55,658 shares as the company’s stock declined 5.44% while stock markets rallied. The institutional investor held 4.53M shares of the edp services company at the end of 2018Q2, valued at $299.71 million, down from 4.58M at the end of the previous reported quarter. Fil Ltd who had been investing in Amdocs Ltd for a number of months, seems to be less bullish one the $9.33 billion market cap company. The stock increased 0.02% or $0.01 during the last trading session, reaching $65.98. About 731,851 shares traded or 14.07% up from the average. Amdocs Limited (NASDAQ:DOX) has risen 2.49% since September 30, 2017 and is uptrending. It has underperformed by 13.13% the S&P500.

Fil Ltd, which manages about $66.31 billion US Long portfolio, upped its stake in Ca Inc (NASDAQ:CA) by 144,155 shares to 2.62M shares, valued at $93.48 million in 2018Q2, according to the filing. It also increased its holding in Jd Com Inc (NASDAQ:JD) by 2.66M shares in the quarter, for a total of 10.23 million shares, and has risen its stake in Diamondback Energy Inc (NASDAQ:FANG).

Analysts await Amdocs Limited (NASDAQ:DOX) to report earnings on November, 14. They expect $0.92 earnings per share, up 4.55 % or $0.04 from last year’s $0.88 per share. DOX’s profit will be $130.12M for 17.93 P/E if the $0.92 EPS becomes a reality. After $0.97 actual earnings per share reported by Amdocs Limited for the previous quarter, Wall Street now forecasts -5.15 % negative EPS growth.

More news for Amdocs Limited (NASDAQ:DOX) were recently published by:, which released: “New Research Coverage Highlights Sanofi, Amdocs, GlaxoSmithKline plc, BT Group, Sociedad Quimica y Minera SA …” on September 26, 2018.‘s article titled: “PLDT, Amdocs sign new agreement to transform PLDT and Smart’s IT infrastructure” and published on September 28, 2018 is yet another important article.

Amdocs Limited (NASDAQ:DOX) Ratings Coverage

Among 3 analysts covering Amdocs (NASDAQ:DOX), 2 have Buy rating, 0 Sell and 1 Hold. Therefore 67% are positive. Amdocs had 3 analyst reports since April 30, 2018 according to SRatingsIntel. Oppenheimer maintained Amdocs Limited (NASDAQ:DOX) on Friday, May 11 with “Buy” rating. Citigroup maintained Amdocs Limited (NASDAQ:DOX) on Thursday, August 2 with “Buy” rating.

Amdocs Limited (NASDAQ:DOX) Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: